Adamis Pharmaceuticals Provides Update on SYMJEPI Products

NEXT STORY
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
PREV STORY
Allogene Therapeutics Announces Ton Schumacher, Ph.D., Chair of Scientific Advisory Board, Awarded the Dutch Research Council’s Stevin Prize
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CORRECTING and REPLACING: Athenex, Inc.

In a release issued earlier today by Athenex, Inc. (Nasdaq:ATNX), please note that the ...

author_avatar
NASDAQ Market News

AMAG Announces First Patient Enrolled in Phase 2b/3a Digoxin Immune Fab Study Conducted by Velo Bio

WALTHAM, Mass., June 01, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced ...

author_avatar
NASDAQ Market News

Mateon Announces Preclinical Data Indicating Enhanced Tumor Immune Response of CA4P with Checkpoint Inhibitor

Addition of CA4P simultaneously reduces tumor volume and increases tumor white blood cells, T ...

author_avatar
NASDAQ Market News